Skip to Content

Galsulfase

In the US, Galsulfase (galsulfase systemic) is a member of the drug class lysosomal enzymes and is used to treat Mucopolysaccharidosis Type VI.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A16AB08

CAS registry number (Chemical Abstracts Service)

0552858-79-4

Chemical Formula

C2529-H3843-N689-O716-S16

Molecular Weight

55867

Therapeutic Category

Enzyme

Chemical Name

N-Acetylgalactosamine 4-sulfatase (human CSL4S-342 cell) (WHO)

Foreign Names

  • Galsulfasum (Latin)
  • Galsulfase (German)
  • Galsulfase (French)
  • Galsulfasa (Spanish)

Generic Names

Brand Names

  • Naglazyme
    AnGes MG, Japan; BioMarin, Czech Republic; BioMarin, Germany; BioMarin, Denmark; BioMarin, Netherlands; BioMarin, Taiwan; BioMarin, United States; BioMarin Europe, Spain; BioMarin Europe, France; BioMarin Europe, Lithuania; BioMarin Europe, Sweden; Biomarin Europe-GB, Italy; DRAC, Switzerland; LCA, Belgium; Medical Intertrade, Croatia (Hrvatska)

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide